List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 1456 studies with search of:   Switzerland
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Active, not recruiting B-Type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice
Condition: Dyspnea
Intervention: Procedure: BNP guided diagnostics and initial therapy
22 Recruiting Clazosentan in Reducing Vasospasm-Related Morbidity and All-Cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping
Condition: Aneurysmal Subarachnoid Hemorrhage
Interventions: Drug: clazosentan;   Drug: placebo
23 Completed Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM
Condition: Hypertension
Interventions: Drug: Telmisartan;   Drug: Ramipril
24 Completed AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes
Condition: Non-Insulin-Dependent Diabetes Mellitus
Interventions: Drug: metformin;   Drug: sulphonylurea;   Drug: Avandamet
25 Recruiting Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU)
Condition: Continuous Sedation in Initially Sedated Adults in ICU
Interventions: Drug: Dexmedetomidine;   Drug: Midazolam
26 Recruiting Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: everolimus;   Procedure: molecular diagnostic method;   Procedure: polymerase chain reaction
27 Active, not recruiting Drugs to Reduce the Side Effects of Chemotherapy
Conditions: Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dexamethasone;   Drug: granisetron hydrochloride;   Drug: metoclopramide hydrochloride
28 Terminated The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-Induced Changes in GERD-Related Symptoms (BY1023/NL511)
Conditions: Gastroesophageal Reflux Disease;   Non-Erosive Reflux Disease
Intervention: Drug: Pantoprazole
29 Active, not recruiting Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Procedure: in vitro sensitivity-directed chemotherapy
30 Completed Nexium Dyspepsia/AST
Conditions: Gastrointestinal Disease;   Signs and Symptoms, Digestive;   Dyspepsia
Intervention: Drug: Esomeprazole
31 Active, not recruiting Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: CHOP regimen;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: filgrastim;   Drug: leucovorin calcium;   Drug: melphalan;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: mitoxantrone hydrochloride;   Drug: prednisone;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
32 Recruiting A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
Condition: Coronary Heart Disease
Interventions: Drug: RO4607381;   Drug: Placebo;   Drug: Evidence-based medical care for Acute Coronary Syndrome
33 Recruiting Combination Chemotherapy After Surgery in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: CAF regimen;   Drug: CMF regimen;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: fluorouracil;   Drug: methotrexate;   Procedure: adjuvant therapy
34 Recruiting Treatment of Refractory Status Epilepticus
Condition: Status Epilepticus
Interventions: Drug: propofol;   Drug: thiopental/pentobarbital
35 Completed The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)
Condition: Peripheral Arterial Disease
Interventions: Drug: Aspirin;   Drug: Clopidogrel
36 Recruiting Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: radiation therapy
37 Recruiting Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: filgrastim;   Drug: ifosfamide;   Drug: iodine I 131 metaiodobenzylguanidine;   Drug: isotretinoin;   Drug: melphalan;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: radiation therapy
38 Completed Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)
Condition: Asthma
Intervention: Drug: Ciclesonide
39 Recruiting Health Economic Evaluation of Primovist-Enhanced Liver MRI
Conditions: Colorectal Neoplasms;   Neoplasm Metastasis
Interventions: Procedure: Primovist MRI;   Procedure: Extracellular contrast media (ECCM) MRI;   Procedure: Contrast-enhanced CT
40 Completed Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
Conditions: Cerebral Stroke;   Stroke, Acute;   Cerebrovascular Stroke;   Ischemic Attack, Transient
Intervention: Drug: NXY-059

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services